NCT05985941View on ClinicalTrials.gov

Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors

Not yet recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions

Rare Gynecological TumorsMulti-omics Analysis

All Listed Sponsors

lead

RenJi Hospital

OTHER

NCT05985941 - Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors | Biotech Hunter | Biotech Hunter